IFNA1 and severe acute respiratory syndrome: Current treatments for SARS mainly include ribavirin, IFN α, plasma therapy, host-directed therapies, and systemic corticosteroids.14,41 Due to the lack of clinical trial data, adequate supportive care supplemented with different combinations of drugs remains the main treatment for patients.14,41